|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
zur Hausen H: Human papillomaviruses in
the pathogenesis of anogenital cancer. Virology. 184:9–13. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu YJ, Soumelis V, Watanabe N, Ito T,
Wang YH, Malefyt Rde W, Omori M, Zhou B and Ziegler SF: TSLP: An
epithelial cell cytokine that regulates T cell differentiation by
conditioning dendritic cell maturation. Annual Annu Rev Immunol.
25:193–219. 2007. View Article : Google Scholar
|
|
4
|
Sokol CL, Barton GM, Farr AG and Medzhitov
R: A mechanism for the initiation of allergen-induced T helper type
2 responses. Nat Immunol. 9:310–318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rochman Y and Leonard WJ: Thymic stromal
lymphopoietin: A new cytokine in asthma. Curr Opin Pharmacol.
8:249–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu YJ: Thymic stromal lymphopoietin and
OX40 ligand pathway in the initiation of dendritic cell-mediated
allergic inflammation. J Allergy Clin Immunol. 120:238–246. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park LS, Martin U, Garka K, Gliniak B, Di
Santo JP, Muller W, Largaespada DA, Copeland NG, Jenkins NA, Farr
AG, et al: Cloning of the murine thymic stromal lymphopoietin
(TSLP) receptor: Formation of a functional heteromeric complex
requires interleukin 7 receptor. J Exp Med. 192:659–670. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reche PA, Soumelis V, Gorman DM, Clifford
T, Liu Mr, Travis M, Zurawski SM, Johnston J, Liu YJ, Spits H, et
al: Human thymic stromal lymphopoietin preferentially stimulates
myeloid cells. J Immunol. 167:336–343. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie F, Liu LB, Shang WQ, Chang KK, Meng
YH, Mei J, Yu JJ, Li DJ and Li MQ: The infiltration and functional
regulation of eosinophils induced by TSLP promote the proliferation
of cervical cancer cell. Cancer Lett. 364:106–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xie F, Meng YH, Liu LB, Chang KK, Li H, Li
MQ and Li DJ: Cervical carcinoma cells stimulate the angiogenesis
through TSLP promoting growth and activation of vascular
endothelial cells. Am J Reprod Immunol. 70:69–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang B, Wei CY, Chang KK, Yu JJ, Zhou WJ,
Yang HL, Shao J, Yu JJ, Li MQ and Xie F: TSLP promotes angiogenesis
of human umbilical vein endothelial cell by strengthening crosstalk
between cervical cancer cells and eosinophils. Oncol Lett. DOI:
10.3892/ol.2017.7121.
|
|
12
|
Watanabe J, Saito H, Miyatani K, Ikeguchi
M and Umekita Y: TSLP expression and high serum TSLP level indicate
a poor prognosis in gastric cancer patients. Yonago Acta Med.
58:137–143. 2015.PubMed/NCBI
|
|
13
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao JL, Zhang L, Guo X, Wang JH, Zhou W,
Liu M, Li X and Tang H: miR-212/132 downregulates SMAD2 expression
to suppress the G1/S phase transition of the cell cycle and the
epithelial to mesenchymal transition in cervical cancer cells.
IUBMB Life. 67:380–394. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyazono K, Suzuki H and Imamura T:
Regulation of TGF-beta signaling and its roles in progression of
tumors. Cancer Sci. 94:230–234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Massagué J: TGFβ in cancer. Cell.
134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu Y, Ohba T, Ando T, Fujita K, Koyama K,
Nakamura Y, Katoh R, Haro H and Nakao A: Endogenous TGF-β activity
limits TSLP expression in the intervertebral disc tissue by
suppressing NF-κB activation. J Orthop Res. 31:1144–1149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang ZH, Zhang QS, Duan YL, Zhang JL, Li
GF and Zheng DL: TGF-β induced miR-132 enhances the activation of
TGF-β signaling through inhibiting SMAD7 expression in glioma
cells. Biochem Biophys Res Commun. 463:187–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Yu H, Cai H and Wang Y: The
expression and clinical significance of miR-132 in gastric cancer
patients. Diagn Pathol. 9:572014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y,
Wang QS, Li SB, Xiao GC and Tong SL: miR-132 inhibits colorectal
cancer invasion and metastasis via directly targeting ZEB2. World J
Gastroenterol. 20:6515–6522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Formosa A, Lena AM, Markert EK, Cortelli
S, Miano R, Mauriello A, Croce N, Vandesompele J, Mestdagh P,
Finazzi-Agrò E, et al: DNA methylation silences miR-132 in prostate
cancer. Oncogene. 32:127–134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang ZG, Chen WX, Wu YH, Liang HF and
Zhang BX: MiR-132 prohibits proliferation, invasion, migration, and
metastasis in breast cancer by targeting HN1. Biochem Biophys Res
Commun. 454:109–114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li S, Meng H, Zhou F, Zhai L, Zhang L, Gu
F, Fan Y, Lang R, Fu L, Gu L and Qi L: MicroRNA-132 is frequently
down-regulated in ductal carcinoma in situ (DCIS) of breast and
acts as a tumor suppressor by inhibiting cell proliferation. Pathol
Res Pract. 209:179–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Tang W, Li R, He R, Gan T, Luo Y,
Chen G and Rong M: Downregulation of microRNA-132 indicates
progression in hepatocellular carcinoma. Exp Ther Med.
12:2095–2101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang S, Hao J, Xie F, Hu X, Liu C, Tong
J, Zhou J, Wu J and Shao C: Downregulation of miR-132 by promoter
methylation contributes to pancreatic cancer development.
Carcinogenesis. 32:1183–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo G, Long J, Cui X, Xiao Z, Liu Z, Shi
S, Liu L, Liu C, Xu J, Li M and Yu X: Highly lymphatic metastatic
pancreatic cancer cells possess stem cell-like properties. Int J
Oncol. 42:979–984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Q, Liao F, Wu H, Cai T, Yang L, Wang
ZF and Zou R: Upregulation of miR-132 expression in glioma and its
clinical significance. Tumor Biol. 35:12299–12304. 2014. View Article : Google Scholar
|
|
30
|
Zhu H, Luo H, Shen Z, Hu X, Sun L and Zhu
X: Transforming growth factor-β1 in carcinogenesis, progression,
and therapy in cervical cancer. Tumor Biol. 37:7075–7083. 2016.
View Article : Google Scholar
|
|
31
|
Sun SH, Liu D, Deng YT, Zhang XX, Wan DY,
Xi BX, Huang W, Chen Q, Li MC, Wang MW, et al: SIX1 coordinates
with TGFβ signals to induce epithelial-mesenchymal transition in
cervical cancer. Oncol Lett. 12:1271–1278. 2016.PubMed/NCBI
|
|
32
|
Torres-Poveda K, Bahena-Román M,
Madrid-González C, Burguete-García AI, Bermúdez-Morales VH,
Peralta-Zaragoza O and Madrid-Marina V: Role of IL-10 and TGF-β1 in
local immunosuppression in HPV-associated cervical neoplasia. World
J Clin Oncol. 5:753–763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin H, Huang CC, Ou YC, Huang EY,
Changchien CC, Tseng CW, Fu HC, Wu CH, Li CJ and Ma YY: High
immunohistochemical expression of TGF-β1 predicts a poor prognosis
in cervical cancer patients who harbor enriched endoglin
microvessel density. Int J Gynecol Pathol. 31:482–489. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yao C, Shi X, Zhang Z, Zhou S, Qian T,
Wang Y, Ding F, Gu X and Yu B: Hypoxia-Induced upregulation of
miR-132 promotes schwann cell migration after sciatic nerve injury
by targeting PRKAG3. Mol Neurobiol. 53:5129–5139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hong S, Lee J, Seo HH, Lee CY, Yoo KJ, Kim
SM, Lee S, Hwang KC and Choi E: Na(+)-Ca(2+) exchanger targeting
miR-132 prevents apoptosis of cardiomyocytes under hypoxic
condition by suppressing Ca(2+) overload. Biochem Biophys Res
Commun. 460:931–937. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Piri R, Ghaffari A, Azami-Aghdash S,
Ali-Akbar YP, Saleh P and Naghavi-Behzad M: Ki-67/MIB-1 as a
prognostic marker in cervical cancer-a systematic review with
meta-analysis. Asian Pac J Cancer Prev. 16:6997–7002. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Astudillo H, Lopez T, Castillo S, Gariglio
P and Benitez L: p53, Bcl-2, PCNA expression, and apoptotic rates
during cervical tumorigenesis. Ann N Y Acad Sci. 1010:771–774.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo J, Meng C, Tang Y, Zhang S, Wan M, Bi
Y and Zhou X: miR-132/212 cluster inhibits the growth of lung
cancer xenografts in nude mice. Int J Clin Exp Med. 7:4115–4122.
2014.PubMed/NCBI
|
|
39
|
Libra M, Scalisi A, Vella N, Clementi S,
Sorio R, Stivala F, Spandidos DA and Mazzarino C: Uterine cervical
carcinoma: Role of matrix metalloproteinases (Review). Int J Oncol.
34:897–903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jasińska M, Miłek J, Cymerman IA, Łęski S,
Kaczmarek L and Dziembowska M: miR-132 regulates dendritic spine
structure by direct targeting of matrix metalloproteinase 9 mRNA.
Mol Neurobiol. 53:4701–4712. 2016. View Article : Google Scholar : PubMed/NCBI
|
